or pre-annotated scRNA-seq data, ideally under the same experimental design using the 50 same platform, which is often not available. Using prior knowledge of cell-type specific 51 marker genes increased the accuracy and efficiency of cell type assignment, allowing 52 for identification of both known and de novo cell types in scRNA-seq data of complex 53 tissues, as shown by CellAssign and Garnett (Pliner et al., 2019a) . 54 approach. Unsupervised clustering methods based on dimension reduction algorithms 56 such as principal component analysis (PCA) and t-distributed stochastic neighbor 57 embedding (t-SNE) have been developed to partition the cells based on the similarity 58 of their gene expression patterns (Bacher and Kendziorski, 2016; Kiselev et al., 2019) . 59
And users could manually assign a cell type to each cluster based on differentially 60 expressed markers by consulting the literature for cell-type specific gene markers. 61
However, there is still some problem associated with the manual annotation step. For 62 example, the canonical marker genes used in the assignment process may have an 63 impact on the annotation accuracy, which may lead to biased results with uncontrolled 64 vocabularies for cell type labels in different datasets. Expert-curated knowledge 65 databases such as CellMarker and CancerSEA (Yuan et al., 2019b) , 66 have been developed to provide a comprehensive and unified resource of cell markers 67 for various cell types in human and mouse tissues. Yet it is still lack a method to 68 leverage the information in these databases for annotation. Furthermore, marker genes 69 could express in more than one cell type, make the annotation more complex for human 70 to process. 71
To overcome these difficulties and to streamline the cell type assignment process for 72 scRNA-seq data, we developed SCSA, an algorithm that can automatically assign cell 73 types for each cell cluster in scRNA-seq data. SCSA uses marker genes of known cell 74 types highly expressed in a cell cluster to label the cluster. It can be directly applied to 75 clustering results generated from other scRNA-seq analysis softwares such as 76 types. Furthermore, SCSA can accept user-defined marker gene database as additional 106 information for cell cluster annotation. The user-defined marker gene database must 107 have two columns, with the name of cell types in the first column and marker gene for 108 each cell type in the second column. In that case, SCSA will combine both known 109 databases and the custom database to predict the annotations for cell clusters. 110
For those genes which existed in both the DEGs and known cell marker databases, 113 SCSA constructs a cell-gene sparse matrix (defined as ( = 1 3$ 4 5 6 ×7 6 ) with ( ( ( ≤ 114 i) cells and ( ( ( ≤ j) genes as "marker evidence". Here, for each cell and each 115 gene j in the matrix ( , refers to the sum number of references in the CellMarker 116 database. To eliminate the huge differences of marker evidence between the well-117 known gene and less-known genes, we transform the value to log2-based and plus a 118 constant (0.05). Also, to represent the whole gene set for a certain cell, we create a cell 119 type style vector which takes multiplication of standard deviation of the marker 120 evidence and marker numbers (defined as ( = { ( , * , ⋯ 5( } , where = ( 3$ ) * 121
( 3$ > 0)). So, for the known marker database, the raw score vector of a cell type 122 
Finally, an annotation model will be constructed by merging the database weight 140 coefficient matrix and the last uniform score vector. 141 (https://www.10xgenomics.com/resources/datasets). The 3k and 6k data were blood 183 samples from one donor generated using the v1. chemistry and preprocessed with 184 CellRanger1.1.0. They were labeled "3k PBMCs from a healthy donor" and "6k 185 PBMCs from a healthy donor", respectively. The 4k and 8k datasets, under the label 186 "4k PBMCs from a healthy donor" and "8k PBMCs from a healthy donor", were 187 samples collected from one donor, generated using the v2. Chemistry and preprocessed 188 using CellRanger2.1.0. 189
190

Evaluation of SCSA performance on real datasets 191
For the known cell type datasets, we defined cell type cluster by their real cell types. 
Results
233
Design principles of SCSA 234
The SCSA algorithm is a three-step procedure that includes marker genes identification, 235 annotation model construction, and GO enrichment analysis (Figure 1) . First, the input 236 of SCSA is a gene expression matrix with cell cluster information (such as the output 237 results of CellRanger or Seurat). SCSA identifies a group of marker genes for each 238 cluster from input expression matrix by differential gene expression analysis. Next, for 239 each cluster, genes identified as marker genes that have one or more linked cell types 240 in a database will be used to generate a cell-gene matrix for that cluster. For each cell 241 type in the matrix, SCSA then used a decision model to assign a score by combining 242 the enrichment of marker gene expression and the strength of evidence for the marker 243 genes in the database. SCSA could also take marker gene information from multiple 244 databases and assign different weights to them. Finally, SCSA provides an alternative 245 gene ontology enrichment analysis step to give some clues to the user for the function 246 of a cell cluster in addition to its annotation. 247 cell types (Table S1) 
cells, Endothelial cells, Epithelial cells, Myeloid and T cells, and 267
identified "Fibroblast" group as "MSC" and "Alveolar" as "Epithelial Cell" (Table S2 , 268 S3). 269
In order to evaluate the robustness of SCSA on large scRNA-seq datasets, we used 270 four PBMCs (3k, 4k, 6k and 8k) datasets from 10X genomics website. We collected all 271 possible cell types of a cell cluster according to the top five scores under the score 272 annotation model of SCSA. The correlation of all cell types and scores were calculated 273 and compared. As shown in Figure 3A , based on the five annotated cell types 274
(monocyte cells, T cells, NK cells, megakaryocytes cells, and B cells) of CellRanger, 275
annotated as "monocytes" by SCSA due to the reason that they share many marker 278
genes. 279
To further demonstrate the robustness of SCSA over the five annotated cell types 280 (monocytes cells, T cells, NK cells, megakaryocytes cells, and B cells), we compared 281 their abundance in each cluster using the four PBMCs datasets. As shown in Figure 3B , 282 the percentages of cell numbers for five cell types annotated by SCSA remained stable 283 across these datasets. T cells occupied half of the PBMCs, and monocytes cell 284 represented another 25%, B cells and NK cells had similar levels, while 285 megakaryocytes cell has the lowest number among all the five cell types. Meanwhile, 286 as shown in Figure 3C , SCSA can predicted the five cell types consistent with the 287 reference information of 4 PBMCs. 288
In addition, to test the GO module in SCSA, which is designed to give some clues 289 on cluster cell function in addition to its label, we collected gene expression profiles of 290 primary cells and cell lines from FANTOM5+SingleR dataset, which contains both 291 human and mouse cell types (Table S8 ). For cell types with 10 or more samples, SCSA 292 achieved a 60% (15 of 25) and a 57% (12 of 21) accuracy for human and mouse data 293 respectively. For cell types containing more than 40 samples, the accuracy of SCSA 294 were improved to 73% (8 of 11) for human data and achieved 56% (5 of 9) for mouse 295 data, respectively (Table S2 ). For the "Aortic smooth muscle cell" cell type, which was 296 not identified correctly due to lack of evidence in the CellMarker reference database, a 297 GO analysis step in SCSA revealed a functional enrichment in the term "extracellular 298 matrix structural constituent", suggesting its role in regulating cell shape and cross-talk 299 with extracellular matrix (Owens et al., 2004) . 300 301
Comparison to other cell type annotation tools 302
We compared the performance of SCSA with three other tools (scMatch (Hou et al., 303 known cell type datasets. Since scMatch, CellAssign and Garnett annotate each of the 305 single cells instead of cell clusters, all cells were first annotated and a cell type with the 306 maximum occurrence in the cluster was defined as the final predicted result of the 307 cluster (Table S2-S8). As showed in Figure 2 , for the three human tumor datasets 308 (GSE72756, GSE81861 and E-MTAB-6149), SCSA achieved the highest accuracy. 309 scMatch owned the similar accuracy with Garnett when using the predefined lung 310 classifier (Garnett_human_lung) on the three human tumor datasets. CellAssign had a 311 better prediction results than Garnett on GSE72756 and GSE81861 datasets, with 83% 312 and 86% accuracy, respectively. However, for E-MTAB-6149 dataset with more than 313 45,000 cells, CellAssign only yielded 43% accuracy which was lower than Garnett 314 using pre-trained classifier from human lung (Garnett_human_lung) (71%). A possible 315 explanation for these might be that CellAssign was not suitable to annotate cell types 316 for large datasets. Another possible explanation for these was that E-MTAB-6149 317 dataset is the training-set of pre-trained classifier of Garnett. 318
Cell-based annotation approaches could assign multiple cell type labels to one 319 cluster due to cell heterogeneity in the clusters. Evaluation results of CellAssign in E-320 MTAB-6149 illustrated that only 8 (0.1%) of B cells were correctly assigned for true B 321 cell cluster, whereas 2,861 (51.1%) cells were mistakenly assigned as myofibroblast 322 cells and 1,755 (31.3%) cells were not able to assign a clear cell type. In general，most 323 predicted cell types in the cluster (>50%) from these tools were not consistent with true 324 cell type. For example, the T cells of E-MTAB-6149 dataset was not annotated by 325
CellAssign, the fibroblasts of GSE81861 dataset was missed by scMatch, and the 326 natural killer cells of GSE72056 dataset were not identified by CellAssign and scMatch 327 (Table S2, In cell type annotation, it is usually hard to find high-quality marker genes to 345 describe a cell cluster. A strategy is to use genes specifically expressed in a cell cluster 346 to mark the cell type. However, using a few marker genes is often not sufficient to 347 distinguish a cell cluster from the others. In addition, using the whole expressed gene 348 sets may decrease the power to find the true patterns within each cell cluster. Therefore, 349 we used DEGs in the marker gene identification step in SCSA. This step avoids the 350 influence of ubiquitously expressed genes and collects the appropriate genes for 351 calculating the optimal score in the annotation model. There still exist some limitations, 352 which may influence the accuracy of cell type annotation using SCSA. First, the 353 quantity of marker genes in these cell marker databases greatly impacted the results of 354 cell type annotation. Since cell marker collection is far away from completion, it is 355 possible that some cell types are unclassifiable due to the lack of appropriate markers. 356
Specifically, this phenomenon is quite common for unknown tissues and novel sub-357 clusters of cells at different states. User-defined marker combinations need to be 358 developed to solve this problem. SCSA can accept them as additional information to 359 improve the annotation results. Second, for complex tissues such as cancer tissues, the accuracy of cell annotation is heavily relied on the clustering algorithms. Different 361 unsupervised clustering method could have different results, especially when the cluster 362 size is unevenly distributed in the population (Kiselev et al., 2019) . In that situation, 363 algorithms using supervised clustering may be more appropriate for cell type 364 classification (Pliner et al., 2019b) . 365
Compared with the results of SCSA over different datasets, SCSA exhibited a 366 reasonable accuracy and robustness in cell type annotation. Further efforts could be 367 made to improve the annotation ability of SCSA by taking into account more 368 information (e.g., the more accurate information of cell marker genes, the 369 comprehensive clustering algorithm). We believe that SCSA is an important addition to 370 the toolbox used for single-cell studies and will greatly improve our efficiency and 371 capacity to explore the functional potential of novel cell types. 
